RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Altimmune Stock

Altimmune Dividend 2025

Altimmune Dividend

0 USD

Altimmune Dividend yield

21,031.08 %

Ticker

ALT

ISIN

US02155H2004

WKN

A2N5Z6

How much dividend does Altimmune 2025 pay?

According to the latest status from July 2025, Altimmune paid a total of 0 USD per share in dividends within the last 12 months. With the current Altimmune price of 4.15 USD, this corresponds to a dividend yield of 0 %. A dividend is paid times per year.

21,031.08 % Dividend Yield=
873 USD Dividend
4.15 USD Stock Price

Historical Altimmune Dividends

A dividend is paid times per year. Last year, the payout months were and .

PaydateDividend
3/6/20172.91
1

Altimmune dividend history and estimates

In 2024, Altimmune paid a dividend amounting to 0 USD. Dividend means that Altimmune distributes a portion of its profits to its owners.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details

Dividend

ⓘ

Dividend Overview

The dividend per year chart for Altimmune provides a comprehensive view of the annual dividends distributed to shareholders. Analyze the trend to understand the consistency and growth in dividend payouts over the years.

Interpretation and Use

A consistent or increasing trend in dividends can indicate the company's profitability and financial health. Investors can use this data to identify Altimmune’s potential for long-term investment and income generation through dividends.

Investment Strategy

Incorporate the dividend data in evaluating Altimmune's overall performance. A thorough analysis, considering other financial aspects, will help in making informed investment decisions for optimal capital growth and income generation.

Altimmune Dividend History

DateAltimmune Dividend
2017873 undefined

Is the Altimmune Dividend Safe?

Altimmune has been increasing the dividend for 1 years.

Over the past 10 years, Altimmune has increased it by an annual 0 %.

Over a five-year period, the distribution increased by 0%.

Analysts expect a Dividend Cut of -100% for the current fiscal year.

Altimmune dividend payout ratio

In 2024, Altimmune had a payout ratio of 0%. The payout ratio indicates the percentage of the company's profits that Altimmune distributes as dividends.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Payout ratio
Details

Payout ratio

ⓘ

What is Yearly Payout Ratio?

The yearly payout ratio for Altimmune represents the proportion of earnings paid out as dividends to shareholders. It is an indicator of the company's financial health and stability, illustrating how much profit is being returned to investors versus being reinvested back into the company.

How to Interpret the Data

A lower payout ratio for Altimmune could mean that the company is reinvesting more into its growth, whereas a higher ratio indicates more earnings are being distributed as dividends. Investors seeking regular income might prefer companies with a higher payout ratio, while those looking for growth may opt for companies with a lower ratio.

Using the Data for Investments

Evaluate Altimmune's payout ratio in conjunction with other financial metrics and performance indicators. A sustainable payout ratio, coupled with strong financial health, can indicate a reliable dividend payout. However, a very high ratio might suggest the company is not sufficiently reinvesting in its future growth.

Altimmune Payout Ratio History

DateAltimmune Payout ratio
2030e0 %
2029e0 %
2028e0 %
2027e0 %
2026e0 %
2025e0 %
20240 %
20230 %
20220 %
20210 %
20200 %
20190 %
20180 %
2017-730.91 %
20160 %
20150 %
20140 %
20130 %
20120 %
20110 %
20100 %
20090 %
20080 %
20070 %
20060 %
20050 %

Dividend Details

Understanding Altimmune's Dividend Distributions

Altimmune’s dividends are a portion of the company’s profits distributed to shareholders. It is a critical indicator of the company’s financial health and attractiveness to investors. Dividends provide investors with a steady income stream, in addition to any profits that may come from selling the stock at a higher price than the purchase price.

Year-to-Year Comparison

Examining Altimmune's dividend distributions over the years can highlight the company’s profitability and stability. A consistent or increasing dividend payout can indicate a financially healthy company with predictable earnings, while fluctuations or reductions in dividends can suggest underlying financial or operational challenges.

Impact on Investments

Altimmune's dividend payments are an essential factor for income-focused investors. A robust dividend payout can enhance the stock’s appeal, offering regular income in addition to potential capital gains. It also can indicate the company's confidence in its future earnings, making it a significant consideration in investment decisions.

Interpreting Dividend Fluctuations

Changes in Altimmune’s dividends can result from shifts in the company’s earnings, financial policies, or reinvestment strategies. An increase in dividends often signals financial stability, while a decrease may indicate a need to conserve cash or reinvest profits to fuel growth, each scenario having different implications for investors.

Altimmune Aktienanalyse

What does Altimmune do?

Altimmune Inc is a biopharmaceutical company specializing in the development of immunotherapies. The company was founded in 1997 and is headquartered in Gaithersburg, Maryland, USA. Altimmune is one of the most popular companies on Eulerpool.com.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Frequently Asked Questions about Altimmune stock

How much dividend does Altimmune pay?

Over the past 12 months, Altimmune paid a dividend of 873 USD . This corresponds to a dividend yield of about 21,031.08 %. For the coming 12 months, Altimmune is expected to pay a dividend of 0 USD.

What is the dividend yield of Altimmune?

The current dividend yield of Altimmune is 21,031.08 %.

When does Altimmune pay dividends?

Altimmune pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Altimmune?

Altimmune paid dividends every year for the past 0 years.

What is the dividend of Altimmune?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Altimmune located?

Altimmune is assigned to the 'Health' sector.

Wann musste ich die Aktien von Altimmune kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Altimmune from 2/3/2017 amounting to 2.91 USD, you needed to have the stock in your portfolio before the ex-date on 2/6/2017.

When did Altimmune pay the last dividend?

The last dividend was paid out on 2/3/2017.

What was the dividend of Altimmune in the year 2024?

In the year 2024, Altimmune distributed 0 USD as dividends.

In which currency does Altimmune pay out the dividend?

The dividends of Altimmune are distributed in USD.

Andere Kennzahlen von Altimmune

Our stock analysis for Altimmune Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Altimmune Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.